Better quality of end-of-life care for persons with advanced dementia in nursing homes compared to hospitals: a Swedish national register study

Lisa Martinsson; Staffan Lundström; Johan Sundelöf

doi:10.1186/s12904-020-00639-5

Table 3 Logistic regression model comparing 12 end-of-life care outcomes for three age groups (in years) and for men and women, adjusted for place of death (hospital/nursing home). Odds ratios (OR) and 95% confidence intervals (CI) are reported

From: Better quality of end-of-life care for persons with advanced dementia in nursing homes compared to hospitals: a Swedish national register study

	n	%	OR	95% CI	p
PRN drugs against pain
Age
41–64	88/95	92.6	1.006	0.464–2.185	0.987
65–84	4799/5086	94.4	1.335	1.159–1.537	< 0.001
85–110	10,413/11,219	92.8	Ref^a
Gender
Women	10,342/11,081	93.3	1.006	0.880–1.149	0.931
Men	4958/5319	93.2	Ref^a
PRN drugs against nausea
Age
41–64	59/94	62.8	1.108	0.726–1.691	0.636
65–84	3131/5037	62.2	1.069	0.997–1.147	0.060
85–110	6814/11,106	61.4	Ref^a
Gender
Women	6832/10,984	62.2	1.038	0.969–1.113	0.285
Men	3172/5253	60.4	Ref^a
PRN drugs against anxiety
Age
41–64	79/94	84.0	0.991	0.568–1.730	0.975
65–84	4342/5063	85.8	1.127	1.024–1.240	0.014
85–110	9455/11,172	84.6	Ref^a
Gender
Women	9405/11,041	85.2	1.017	0.926–1.116	0.728
Men	4471/5288	84.5	Ref^a
Pain assessed and documented during the last week of life
Age
41–64	29/93	31.2	1.025	0.658–1.595	0.914
65–84	1550/4916	31.5	1.039	0.965–1.118	0.313
85–110	3399/10,834	31.4	Ref^a
Gender
Women	3428/10,726	32.0	1.042	0.968–1.121	0.277
Men	1550/5117	30.3	Ref^a
Symptoms other than pain assessed during the last week of life
Age
41–64	22/87	25.3	1.572	0.966–2.560	0.069
65–84	890/4830	18.4	1.049	0.960–1.146	0.294
85–110	1940/10,692	18.1	Ref^a
Gender
Women	1984/10,584	18.7	1.080	0.988–1.181	0.091
Men	868/5025	17.3	Ref^a
Oral health assessed during the last week of life
Age
41–64	78/93	83.9	1.712	0.983–2.981	0.058
65–84	3696/4730	78.1	1.162	1.069–1.263	< 0.001
85–110	7848/10,359	75.8	Ref^a
Gender
Women	7923/10,286	77.0	1.112	1.025–1.206	0.010
Men	3699/4896	75.6	Ref^a
Next of kin informed about transition to end-of-life care
Age
41–64	72/90	80.0	1.630	0.970–2.739	0.065
65–84	3549/4733	75.0	1.224	1.131–1.325	< 0.001
85–110	7308/10,355	70.6	Ref^a
Gender
Women	7331/10,274	71.4	0.959	0.887–1.036	0.289
Men	3598/4904	73.4	Ref^a
Next of kin offered a follow-up talk after death of the patient
Age
41–64	69/84	82.1	1.776	1.005–3.140	0.048
65–84	3119/4152	75.1	1.161	1.064–1.265	0.001
85–110	6772/9258	73.1	Ref^a
Gender
Women	6828/9217	74.1	0.983	0.903–1.071	0.701
Men	3132/4277	73.2	Ref^a
Documented decision to shift to end-of-life care
Age
41–64	75/84	89.3	1.066	0.531–2.141	0.858
65–84	4145/4574	90.6	1.216	1.079–1.371	0.001
85–110	8971/10,050	89.3	Ref^a
Gender
Women	8934/9924	90.0	1.083	0.966–1.215	0.171
Men	4257/4784	89.0	Ref^a
Specialised palliative care team consulted
Age
41–64	3/95	3.2	2.895	0.902–9.293	0.074
65–84	84/5112	1.6	1.461	1.103–1.937	0.008
85–110	127/11,255	1.1	Ref^a
Gender
Women	147/11,120	1.3	1.181	0.877–1.590	0.274
Men	67/5342	1.3	Ref^a
Someone present at the moment of death
Age
41–64	85/93	91.4	1.505	0.720–3.147	0.277
65–84	4554/5043	90.3	1.340	1.197–1.501	< 0.001
85–110	9724/11,035	88.1	Ref^a
Gender
Women	9691/10,915	88.8	0.904	0.811–1.008	0.070
Men	4672/5256	88.9	Ref^a
Pressure ulcers at death
Age
41–64	13/94	13.8	0.829	0.460–1.496	0.534
65–84	767/5055	15.2	0.943	0.859–1.036	0.221
85–110	1717/11,156	15.4	Ref^a
Gender
Women	1613/11,031	14.6	0.876	0.799–0.960	0.005
Men	884/5274	16.8	Ref^a

^a Reference

Back to article page

ISSN: 1472-684X

Contact us

Submission enquiries: bmcpalliativecare@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Palliative Care

Contact us